Kevin received his B.S. in Biology from the University of Georgia in 2017. Shortly after graduating, he joined the Paiardini lab as a Research Specialist in December of 2017. In 2021, he was promoted to lead research specialist. Kevin is in charge of processing a wide range of NHP specimens from SIV/SHIV and Sars-Cov2 studies and he prepares antiretroviral solutions for the entire SIV/SHIV-infected NHP cohort in the lab.